Taufiek Konrad Rajab
Concepts (493)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 44 | 2025 | 367 | 20.810 |
Why?
| Heart Valve Prosthesis | 12 | 2025 | 86 | 7.030 |
Why?
| Heart Valve Prosthesis Implantation | 12 | 2025 | 96 | 6.360 |
Why?
| Tissue Adhesions | 25 | 2021 | 35 | 5.570 |
Why?
| Lung Transplantation | 10 | 2022 | 39 | 4.280 |
Why?
| Aortic Valve | 15 | 2025 | 123 | 4.080 |
Why?
| Tissue Donors | 15 | 2025 | 126 | 4.060 |
Why?
| Pulmonary Valve | 6 | 2025 | 54 | 3.650 |
Why?
| Cardiac Surgical Procedures | 10 | 2024 | 321 | 3.630 |
Why?
| Heart Valves | 9 | 2024 | 25 | 3.530 |
Why?
| Heart Defects, Congenital | 11 | 2024 | 619 | 3.370 |
Why?
| Heart Valve Diseases | 8 | 2025 | 53 | 3.320 |
Why?
| Tissue and Organ Procurement | 8 | 2024 | 49 | 3.120 |
Why?
| Bioprosthesis | 5 | 2025 | 40 | 2.560 |
Why?
| Organ Transplantation | 5 | 2024 | 48 | 2.430 |
Why?
| Humans | 118 | 2025 | 52483 | 2.420 |
Why?
| Organ Preservation | 3 | 2025 | 32 | 2.350 |
Why?
| Postoperative Complications | 13 | 2022 | 1068 | 2.300 |
Why?
| Models, Animal | 9 | 2025 | 234 | 2.150 |
Why?
| Echocardiography | 8 | 2024 | 415 | 2.040 |
Why?
| Bioartificial Organs | 3 | 2020 | 3 | 2.010 |
Why?
| Lung | 7 | 2022 | 509 | 1.860 |
Why?
| Thrombosis | 3 | 2023 | 253 | 1.840 |
Why?
| Animals | 47 | 2025 | 13505 | 1.830 |
Why?
| Child | 23 | 2025 | 7248 | 1.800 |
Why?
| Extracorporeal Membrane Oxygenation | 4 | 2023 | 295 | 1.790 |
Why?
| Cryopreservation | 2 | 2025 | 41 | 1.780 |
Why?
| Peritoneal Diseases | 8 | 2013 | 15 | 1.750 |
Why?
| Swine | 13 | 2025 | 428 | 1.740 |
Why?
| Graft Rejection | 9 | 2024 | 177 | 1.730 |
Why?
| Peritoneum | 8 | 2017 | 16 | 1.700 |
Why?
| Truncus Arteriosus, Persistent | 2 | 2024 | 7 | 1.690 |
Why?
| Immunosuppressive Agents | 3 | 2025 | 243 | 1.680 |
Why?
| Transplantation, Heterologous | 5 | 2024 | 79 | 1.650 |
Why?
| Transplants | 2 | 2023 | 19 | 1.640 |
Why?
| Tissue Scaffolds | 5 | 2020 | 40 | 1.610 |
Why?
| Biocompatible Materials | 7 | 2019 | 67 | 1.600 |
Why?
| Tissue Engineering | 4 | 2020 | 74 | 1.530 |
Why?
| Aortic Valve Stenosis | 3 | 2021 | 76 | 1.400 |
Why?
| Norwood Procedures | 2 | 2021 | 60 | 1.360 |
Why?
| Heart Neoplasms | 3 | 2019 | 32 | 1.320 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2021 | 98 | 1.300 |
Why?
| Heart Failure | 8 | 2024 | 565 | 1.290 |
Why?
| Suture Techniques | 4 | 2014 | 60 | 1.210 |
Why?
| Thoracic Surgery | 3 | 2017 | 22 | 1.200 |
Why?
| Heart-Assist Devices | 4 | 2024 | 163 | 1.150 |
Why?
| Disease Models, Animal | 12 | 2024 | 1478 | 1.140 |
Why?
| Ischemia | 3 | 2014 | 150 | 1.140 |
Why?
| Transplantation, Homologous | 6 | 2023 | 150 | 1.130 |
Why?
| Tacrolimus | 2 | 2025 | 59 | 1.120 |
Why?
| Aortic Valve Insufficiency | 3 | 2022 | 26 | 1.100 |
Why?
| Rats | 19 | 2024 | 3220 | 1.080 |
Why?
| Heart Atria | 3 | 2023 | 63 | 1.070 |
Why?
| Perfusion | 4 | 2022 | 48 | 1.060 |
Why?
| Marfan Syndrome | 2 | 2024 | 26 | 1.050 |
Why?
| Tourniquets | 2 | 2023 | 9 | 1.020 |
Why?
| Forecasting | 3 | 2024 | 154 | 1.000 |
Why?
| Infant, Newborn | 12 | 2024 | 2867 | 0.990 |
Why?
| Rodentia | 2 | 2024 | 17 | 0.960 |
Why?
| Death | 3 | 2020 | 23 | 0.920 |
Why?
| Internship and Residency | 5 | 2017 | 448 | 0.910 |
Why?
| Adult | 28 | 2024 | 14161 | 0.900 |
Why?
| Treatment Outcome | 20 | 2024 | 5422 | 0.900 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.890 |
Why?
| Cryoprotective Agents | 1 | 2024 | 6 | 0.880 |
Why?
| Out-of-Hospital Cardiac Arrest | 2 | 2021 | 26 | 0.870 |
Why?
| Shock, Hemorrhagic | 2 | 2014 | 12 | 0.870 |
Why?
| Pelvic Bones | 2 | 2014 | 13 | 0.870 |
Why?
| Aortic Diseases | 2 | 2022 | 54 | 0.840 |
Why?
| Vena Cava, Superior | 1 | 2023 | 22 | 0.840 |
Why?
| Coronary Vessel Anomalies | 1 | 2024 | 36 | 0.840 |
Why?
| Female | 43 | 2024 | 28171 | 0.830 |
Why?
| Hyaluronic Acid | 4 | 2017 | 38 | 0.810 |
Why?
| Follow-Up Studies | 10 | 2023 | 2279 | 0.810 |
Why?
| Fractures, Bone | 2 | 2014 | 107 | 0.790 |
Why?
| Coronary Artery Bypass | 4 | 2019 | 125 | 0.770 |
Why?
| Rats, Wistar | 12 | 2017 | 193 | 0.750 |
Why?
| Puerperal Disorders | 3 | 2018 | 28 | 0.730 |
Why?
| Informed Consent | 2 | 2013 | 95 | 0.720 |
Why?
| Biological Evolution | 1 | 2021 | 52 | 0.700 |
Why?
| Heart Arrest | 1 | 2023 | 158 | 0.700 |
Why?
| Airway Extubation | 1 | 2021 | 30 | 0.700 |
Why?
| Polymers | 1 | 2020 | 49 | 0.690 |
Why?
| Coronary Aneurysm | 2 | 2010 | 19 | 0.690 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2021 | 140 | 0.660 |
Why?
| Eisenmenger Complex | 1 | 2019 | 2 | 0.650 |
Why?
| Heart-Lung Transplantation | 1 | 2019 | 2 | 0.650 |
Why?
| Dextrocardia | 1 | 2019 | 4 | 0.650 |
Why?
| Fontan Procedure | 1 | 2020 | 68 | 0.640 |
Why?
| Paraganglioma | 1 | 2019 | 14 | 0.640 |
Why?
| Fellowships and Scholarships | 2 | 2017 | 127 | 0.630 |
Why?
| Tracheal Stenosis | 1 | 2019 | 13 | 0.630 |
Why?
| Infant | 8 | 2024 | 3733 | 0.630 |
Why?
| Heart Septal Defects, Atrial | 1 | 2019 | 45 | 0.630 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 261 | 0.620 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 488 | 0.620 |
Why?
| Soybean Oil | 1 | 2018 | 4 | 0.610 |
Why?
| Male | 28 | 2024 | 26761 | 0.610 |
Why?
| Trachea | 1 | 2019 | 57 | 0.600 |
Why?
| Surgical Procedures, Operative | 2 | 2010 | 64 | 0.600 |
Why?
| Proctoscopy | 1 | 2018 | 2 | 0.600 |
Why?
| Digital Rectal Examination | 1 | 2018 | 3 | 0.600 |
Why?
| Phospholipids | 1 | 2018 | 59 | 0.590 |
Why?
| Reperfusion Injury | 1 | 2018 | 70 | 0.570 |
Why?
| Coronary Stenosis | 1 | 2019 | 98 | 0.570 |
Why?
| Abnormalities, Multiple | 1 | 2019 | 166 | 0.570 |
Why?
| Travel | 1 | 2017 | 37 | 0.550 |
Why?
| Pneumonia, Viral | 1 | 2020 | 178 | 0.540 |
Why?
| Retrospective Studies | 14 | 2022 | 6607 | 0.540 |
Why?
| Coronavirus Infections | 1 | 2020 | 188 | 0.530 |
Why?
| Aorta | 3 | 2024 | 165 | 0.530 |
Why?
| Percutaneous Coronary Intervention | 1 | 2020 | 307 | 0.520 |
Why?
| Abdominal Wall | 3 | 2021 | 13 | 0.520 |
Why?
| Education, Medical, Graduate | 2 | 2017 | 219 | 0.500 |
Why?
| Oxygen | 1 | 2018 | 336 | 0.490 |
Why?
| General Surgery | 2 | 2016 | 105 | 0.490 |
Why?
| Pandemics | 1 | 2020 | 585 | 0.480 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 490 | 0.470 |
Why?
| Anticoagulants | 3 | 2023 | 270 | 0.460 |
Why?
| Laparoscopy | 4 | 2010 | 180 | 0.460 |
Why?
| Surgical Instruments | 2 | 2015 | 28 | 0.450 |
Why?
| Intraoperative Period | 1 | 2014 | 46 | 0.440 |
Why?
| Lasers, Semiconductor | 1 | 2013 | 10 | 0.420 |
Why?
| Hypotension | 1 | 2014 | 62 | 0.420 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 7 | 0.410 |
Why?
| Femoral Artery | 1 | 2014 | 103 | 0.410 |
Why?
| Transplantation, Heterotopic | 2 | 2024 | 7 | 0.410 |
Why?
| Hemodynamics | 4 | 2023 | 263 | 0.410 |
Why?
| Prosthesis Design | 3 | 2025 | 256 | 0.400 |
Why?
| Coronary Angiography | 3 | 2024 | 367 | 0.400 |
Why?
| Middle Aged | 14 | 2024 | 13028 | 0.400 |
Why?
| Surgery, Computer-Assisted | 1 | 2013 | 53 | 0.400 |
Why?
| Transplantation, Autologous | 3 | 2020 | 488 | 0.400 |
Why?
| Pregnancy, Ectopic | 2 | 2009 | 9 | 0.400 |
Why?
| Jejunum | 1 | 2012 | 55 | 0.390 |
Why?
| Endoscopy | 1 | 2013 | 123 | 0.390 |
Why?
| Polyesters | 2 | 2010 | 14 | 0.390 |
Why?
| Prednisolone | 1 | 2012 | 56 | 0.390 |
Why?
| Electrocoagulation | 2 | 2009 | 12 | 0.390 |
Why?
| Hyperglycemia | 1 | 2012 | 88 | 0.390 |
Why?
| Coronary Vessels | 2 | 2010 | 166 | 0.380 |
Why?
| Abdominal Injuries | 2 | 2012 | 36 | 0.380 |
Why?
| Pericarditis, Constrictive | 1 | 2011 | 2 | 0.370 |
Why?
| Biomedical Engineering | 3 | 2020 | 4 | 0.370 |
Why?
| Enteral Nutrition | 1 | 2012 | 154 | 0.370 |
Why?
| Pericardiectomy | 1 | 2011 | 6 | 0.370 |
Why?
| Receptors, Tachykinin | 1 | 2011 | 3 | 0.370 |
Why?
| Tomography, X-Ray Computed | 5 | 2020 | 1165 | 0.370 |
Why?
| Hernia, Umbilical | 1 | 2011 | 22 | 0.370 |
Why?
| Syphilis, Cardiovascular | 1 | 2011 | 2 | 0.360 |
Why?
| Adolescent | 6 | 2024 | 6739 | 0.360 |
Why?
| Glucose | 3 | 2012 | 355 | 0.360 |
Why?
| Myxoma | 1 | 2011 | 18 | 0.360 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 166 | 0.360 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2011 | 23 | 0.350 |
Why?
| Kidney Transplantation | 1 | 2013 | 192 | 0.350 |
Why?
| Angina Pectoris | 1 | 2010 | 19 | 0.350 |
Why?
| Microsurgery | 1 | 2010 | 30 | 0.340 |
Why?
| Anastomosis, Surgical | 1 | 2010 | 68 | 0.340 |
Why?
| Aorta, Abdominal | 1 | 2010 | 39 | 0.340 |
Why?
| Vena Cava, Inferior | 1 | 2010 | 65 | 0.330 |
Why?
| Glucans | 2 | 2010 | 10 | 0.330 |
Why?
| Incidence | 3 | 2023 | 1062 | 0.320 |
Why?
| Bioengineering | 2 | 2020 | 3 | 0.320 |
Why?
| Hemangioma | 1 | 2010 | 84 | 0.320 |
Why?
| RNA, Messenger | 3 | 2012 | 1132 | 0.320 |
Why?
| Consent Forms | 1 | 2009 | 6 | 0.320 |
Why?
| Child, Preschool | 3 | 2023 | 4076 | 0.310 |
Why?
| United States | 10 | 2024 | 5192 | 0.310 |
Why?
| Cautery | 1 | 2008 | 3 | 0.310 |
Why?
| Text Messaging | 1 | 2009 | 21 | 0.310 |
Why?
| Ovary | 1 | 2009 | 107 | 0.310 |
Why?
| Gels | 1 | 2008 | 22 | 0.310 |
Why?
| Sutures | 1 | 2008 | 39 | 0.300 |
Why?
| Blood Pressure | 3 | 2023 | 537 | 0.300 |
Why?
| Tuberculosis, Spinal | 1 | 2008 | 4 | 0.300 |
Why?
| Vascular Surgical Procedures | 1 | 2010 | 166 | 0.300 |
Why?
| Reoperation | 2 | 2021 | 465 | 0.300 |
Why?
| Polyglutamic Acid | 1 | 2008 | 1 | 0.290 |
Why?
| Cellulose, Oxidized | 1 | 2008 | 4 | 0.290 |
Why?
| Hydrogels | 1 | 2008 | 23 | 0.290 |
Why?
| Low Back Pain | 1 | 2008 | 31 | 0.290 |
Why?
| Skin, Artificial | 1 | 2007 | 11 | 0.280 |
Why?
| Ontario | 2 | 2017 | 55 | 0.280 |
Why?
| Pregnancy | 7 | 2023 | 2680 | 0.280 |
Why?
| Gelatin | 1 | 2007 | 22 | 0.280 |
Why?
| Uterine Diseases | 1 | 2007 | 10 | 0.280 |
Why?
| Physician-Patient Relations | 1 | 2009 | 143 | 0.280 |
Why?
| Stents | 3 | 2020 | 351 | 0.280 |
Why?
| Skin Transplantation | 1 | 2007 | 44 | 0.270 |
Why?
| Young Adult | 6 | 2024 | 4329 | 0.270 |
Why?
| Lumbar Vertebrae | 1 | 2008 | 104 | 0.270 |
Why?
| Pericardium | 2 | 2021 | 29 | 0.270 |
Why?
| Patient Satisfaction | 1 | 2009 | 284 | 0.270 |
Why?
| Patient Education as Topic | 1 | 2010 | 321 | 0.270 |
Why?
| Heart Arrest, Induced | 2 | 2017 | 7 | 0.270 |
Why?
| Waiting Lists | 2 | 2024 | 55 | 0.270 |
Why?
| Radiography | 3 | 2013 | 470 | 0.260 |
Why?
| Time Factors | 6 | 2025 | 2968 | 0.260 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 509 | 0.250 |
Why?
| Materials Testing | 2 | 2020 | 58 | 0.250 |
Why?
| Injections, Intramuscular | 1 | 2025 | 56 | 0.250 |
Why?
| Half-Life | 1 | 2025 | 88 | 0.240 |
Why?
| Attitude of Health Personnel | 1 | 2009 | 360 | 0.240 |
Why?
| Organ Preservation Solutions | 1 | 2025 | 5 | 0.240 |
Why?
| Burns | 1 | 2007 | 163 | 0.240 |
Why?
| Cold Ischemia | 1 | 2025 | 11 | 0.240 |
Why?
| Physicians | 1 | 2009 | 241 | 0.240 |
Why?
| Aged | 8 | 2023 | 10121 | 0.230 |
Why?
| Graft Survival | 2 | 2022 | 160 | 0.230 |
Why?
| Mycoplasma hyorhinis | 1 | 2024 | 1 | 0.230 |
Why?
| Papio | 1 | 2024 | 21 | 0.230 |
Why?
| Thermography | 2 | 2017 | 11 | 0.230 |
Why?
| Mycoplasma Infections | 1 | 2024 | 7 | 0.230 |
Why?
| Tissue Banks | 1 | 2024 | 9 | 0.220 |
Why?
| Myocardium | 3 | 2011 | 453 | 0.220 |
Why?
| Endocarditis, Bacterial | 1 | 2024 | 43 | 0.210 |
Why?
| Membranes, Artificial | 3 | 2017 | 14 | 0.210 |
Why?
| Rats, Sprague-Dawley | 3 | 2018 | 1563 | 0.210 |
Why?
| Feasibility Studies | 1 | 2025 | 406 | 0.210 |
Why?
| Aorta, Thoracic | 1 | 2024 | 97 | 0.210 |
Why?
| Primates | 1 | 2023 | 22 | 0.210 |
Why?
| Cell Survival | 1 | 2025 | 612 | 0.210 |
Why?
| Blood Coagulation | 1 | 2023 | 64 | 0.210 |
Why?
| Regeneration | 2 | 2021 | 79 | 0.210 |
Why?
| Thigh | 1 | 2023 | 34 | 0.200 |
Why?
| HLA Antigens | 1 | 2023 | 56 | 0.200 |
Why?
| Mycophenolic Acid | 1 | 2022 | 19 | 0.200 |
Why?
| Peritoneal Cavity | 2 | 2013 | 8 | 0.200 |
Why?
| Severity of Illness Index | 3 | 2018 | 1026 | 0.190 |
Why?
| Rats, Inbred Lew | 2 | 2019 | 48 | 0.190 |
Why?
| Vascular Diseases | 1 | 2022 | 76 | 0.190 |
Why?
| Lower Extremity | 1 | 2023 | 100 | 0.190 |
Why?
| Transposition of Great Vessels | 1 | 2022 | 26 | 0.190 |
Why?
| Blood Group Incompatibility | 1 | 2021 | 4 | 0.190 |
Why?
| Pentalogy of Cantrell | 1 | 2021 | 1 | 0.190 |
Why?
| Polytetrafluoroethylene | 1 | 2021 | 33 | 0.190 |
Why?
| Referral and Consultation | 1 | 2024 | 292 | 0.180 |
Why?
| Thorax | 1 | 2021 | 14 | 0.180 |
Why?
| Diverticulum | 1 | 2021 | 21 | 0.180 |
Why?
| Electric Impedance | 1 | 2021 | 49 | 0.180 |
Why?
| Hepatitis, Viral, Human | 1 | 2011 | 8 | 0.180 |
Why?
| Infant, Premature, Diseases | 1 | 2022 | 94 | 0.180 |
Why?
| Mitral Valve | 1 | 2021 | 52 | 0.180 |
Why?
| Herpes Simplex | 1 | 2011 | 23 | 0.180 |
Why?
| Propensity Score | 2 | 2019 | 154 | 0.180 |
Why?
| Metastasectomy | 1 | 2021 | 2 | 0.180 |
Why?
| Abdomen | 2 | 2012 | 75 | 0.180 |
Why?
| Age Factors | 2 | 2024 | 1132 | 0.180 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2021 | 45 | 0.180 |
Why?
| Digestive System Surgical Procedures | 2 | 2012 | 32 | 0.170 |
Why?
| Dyspnea | 2 | 2011 | 78 | 0.170 |
Why?
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 62 | 0.170 |
Why?
| Premature Birth | 1 | 2022 | 153 | 0.170 |
Why?
| Brain Death | 1 | 2020 | 18 | 0.170 |
Why?
| Infant, Newborn, Diseases | 1 | 2020 | 56 | 0.170 |
Why?
| Postoperative Period | 1 | 2020 | 170 | 0.170 |
Why?
| History, 21st Century | 1 | 2020 | 59 | 0.170 |
Why?
| Sarcoma | 1 | 2021 | 72 | 0.160 |
Why?
| Heart | 2 | 2020 | 345 | 0.160 |
Why?
| Graft vs Host Disease | 1 | 2020 | 87 | 0.160 |
Why?
| History, 20th Century | 1 | 2020 | 96 | 0.160 |
Why?
| Ankle Injuries | 1 | 2019 | 10 | 0.160 |
Why?
| Equipment Design | 1 | 2020 | 293 | 0.160 |
Why?
| Pulsatile Flow | 1 | 2019 | 18 | 0.160 |
Why?
| Ventricular Fibrillation | 1 | 2019 | 16 | 0.160 |
Why?
| Interdisciplinary Communication | 1 | 2019 | 57 | 0.160 |
Why?
| Radiography, Thoracic | 1 | 2019 | 67 | 0.160 |
Why?
| Islets of Langerhans | 1 | 2019 | 26 | 0.160 |
Why?
| Survival Analysis | 1 | 2021 | 673 | 0.150 |
Why?
| Health Services Needs and Demand | 1 | 2020 | 159 | 0.150 |
Why?
| Emulsions | 1 | 2018 | 25 | 0.150 |
Why?
| Fat Emulsions, Intravenous | 1 | 2018 | 13 | 0.150 |
Why?
| Temperature | 1 | 2019 | 183 | 0.150 |
Why?
| Proctoscopes | 1 | 2018 | 1 | 0.150 |
Why?
| Heart, Artificial | 1 | 2018 | 3 | 0.150 |
Why?
| Colistin | 1 | 2018 | 3 | 0.150 |
Why?
| Comorbidity | 1 | 2020 | 625 | 0.150 |
Why?
| Anal Canal | 1 | 2018 | 27 | 0.150 |
Why?
| Palliative Care | 1 | 2020 | 214 | 0.150 |
Why?
| Polysaccharides | 1 | 2018 | 57 | 0.150 |
Why?
| Prospective Studies | 2 | 2023 | 2481 | 0.140 |
Why?
| Operative Time | 2 | 2015 | 77 | 0.140 |
Why?
| Pneumonia, Bacterial | 1 | 2018 | 32 | 0.140 |
Why?
| Infrared Rays | 1 | 2017 | 26 | 0.140 |
Why?
| Cecum | 2 | 2008 | 61 | 0.140 |
Why?
| Extracellular Matrix | 1 | 2018 | 112 | 0.140 |
Why?
| Heparin | 1 | 2018 | 88 | 0.140 |
Why?
| Stem Cells | 1 | 2019 | 177 | 0.140 |
Why?
| Pseudomonas Infections | 1 | 2018 | 54 | 0.140 |
Why?
| Prosthesis Implantation | 1 | 2018 | 51 | 0.140 |
Why?
| Monitoring, Intraoperative | 1 | 2017 | 54 | 0.140 |
Why?
| Pseudomonas aeruginosa | 1 | 2018 | 78 | 0.140 |
Why?
| Optical Imaging | 1 | 2017 | 26 | 0.140 |
Why?
| Cell Proliferation | 1 | 2021 | 1023 | 0.140 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2017 | 30 | 0.140 |
Why?
| Combined Modality Therapy | 1 | 2019 | 639 | 0.140 |
Why?
| Colorectal Neoplasms | 1 | 2021 | 294 | 0.140 |
Why?
| Aged, 80 and over | 3 | 2020 | 3392 | 0.130 |
Why?
| Endocarditis, Non-Infective | 1 | 2016 | 1 | 0.130 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 39 | 0.130 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 221 | 0.130 |
Why?
| Thoracoplasty | 1 | 2016 | 3 | 0.130 |
Why?
| Funnel Chest | 1 | 2016 | 10 | 0.130 |
Why?
| Ligation | 2 | 2013 | 60 | 0.130 |
Why?
| Potassium Compounds | 1 | 2015 | 2 | 0.120 |
Why?
| Prosthesis-Related Infections | 1 | 2017 | 107 | 0.120 |
Why?
| Antigens, CD | 1 | 2016 | 218 | 0.120 |
Why?
| Lung Diseases | 1 | 2016 | 88 | 0.120 |
Why?
| Epithelium | 2 | 2012 | 65 | 0.120 |
Why?
| Wounds and Injuries | 2 | 2008 | 309 | 0.120 |
Why?
| Lidocaine | 1 | 2015 | 46 | 0.120 |
Why?
| Lung Neoplasms | 1 | 2021 | 636 | 0.110 |
Why?
| Risk Assessment | 1 | 2019 | 1327 | 0.110 |
Why?
| Curriculum | 1 | 2017 | 398 | 0.110 |
Why?
| Myocardial Contraction | 2 | 2011 | 112 | 0.110 |
Why?
| Risk Factors | 2 | 2020 | 3889 | 0.110 |
Why?
| Free Tissue Flaps | 1 | 2015 | 63 | 0.110 |
Why?
| Survival Rate | 3 | 2021 | 945 | 0.110 |
Why?
| Macrophages | 1 | 2016 | 379 | 0.110 |
Why?
| Germany | 2 | 2010 | 23 | 0.110 |
Why?
| Cell Adhesion | 2 | 2016 | 163 | 0.110 |
Why?
| Esophagectomy | 1 | 2014 | 37 | 0.110 |
Why?
| Bandages | 1 | 2013 | 28 | 0.110 |
Why?
| Laparotomy | 1 | 2013 | 37 | 0.100 |
Why?
| Clinical Competence | 1 | 2016 | 406 | 0.100 |
Why?
| Gastric Bypass | 1 | 2012 | 20 | 0.100 |
Why?
| Heart Diseases | 1 | 2015 | 216 | 0.100 |
Why?
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2012 | 1 | 0.100 |
Why?
| Injections, Intraperitoneal | 1 | 2012 | 57 | 0.100 |
Why?
| Histocytochemistry | 1 | 2012 | 45 | 0.100 |
Why?
| Esophageal Neoplasms | 1 | 2014 | 111 | 0.100 |
Why?
| Succinate Dehydrogenase | 1 | 2012 | 22 | 0.100 |
Why?
| Intraoperative Care | 1 | 2012 | 51 | 0.100 |
Why?
| Cystadenoma, Serous | 1 | 2012 | 5 | 0.100 |
Why?
| Preoperative Care | 1 | 2013 | 173 | 0.100 |
Why?
| Foreign-Body Reaction | 3 | 2017 | 9 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 192 | 0.100 |
Why?
| Pancreatic Ducts | 1 | 2012 | 13 | 0.100 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 59 | 0.090 |
Why?
| Pilot Projects | 2 | 2011 | 721 | 0.090 |
Why?
| Isoproterenol | 1 | 2011 | 55 | 0.090 |
Why?
| Second-Look Surgery | 1 | 2011 | 3 | 0.090 |
Why?
| Random Allocation | 1 | 2012 | 285 | 0.090 |
Why?
| Diagnosis, Differential | 3 | 2012 | 1046 | 0.090 |
Why?
| Acidosis | 1 | 2011 | 41 | 0.090 |
Why?
| Ascites | 1 | 2011 | 32 | 0.090 |
Why?
| Biological Science Disciplines | 1 | 2011 | 2 | 0.090 |
Why?
| Endocardium | 1 | 2011 | 7 | 0.090 |
Why?
| Lasers, Excimer | 1 | 2011 | 3 | 0.090 |
Why?
| Cardiotonic Agents | 1 | 2011 | 82 | 0.090 |
Why?
| Phrenic Nerve | 1 | 2011 | 6 | 0.090 |
Why?
| Heart Injuries | 1 | 2011 | 16 | 0.090 |
Why?
| Mammary Arteries | 1 | 2010 | 8 | 0.090 |
Why?
| AMP-Activated Protein Kinases | 1 | 2010 | 31 | 0.090 |
Why?
| Alopecia | 1 | 2011 | 38 | 0.090 |
Why?
| Tinnitus | 1 | 2011 | 60 | 0.090 |
Why?
| Infertility | 1 | 2010 | 16 | 0.090 |
Why?
| Scoliosis | 1 | 2011 | 62 | 0.090 |
Why?
| Fibrosis | 3 | 2017 | 196 | 0.080 |
Why?
| Laser Therapy | 1 | 2011 | 82 | 0.080 |
Why?
| Disclosure | 1 | 2010 | 41 | 0.080 |
Why?
| Leiomyoma | 1 | 2010 | 23 | 0.080 |
Why?
| Intestinal Obstruction | 1 | 2010 | 38 | 0.080 |
Why?
| Fallopian Tubes | 1 | 2009 | 23 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2010 | 182 | 0.080 |
Why?
| Wounds, Nonpenetrating | 1 | 2011 | 83 | 0.080 |
Why?
| Adenocarcinoma | 1 | 2014 | 405 | 0.080 |
Why?
| Chi-Square Distribution | 1 | 2010 | 288 | 0.080 |
Why?
| Electrosurgery | 1 | 2009 | 9 | 0.080 |
Why?
| Uterine Neoplasms | 1 | 2010 | 60 | 0.080 |
Why?
| Myocardial Ischemia | 1 | 2010 | 121 | 0.080 |
Why?
| Cardiomyopathies | 1 | 2010 | 121 | 0.080 |
Why?
| Pancreatic Neoplasms | 1 | 2012 | 216 | 0.080 |
Why?
| Triplets | 1 | 2009 | 1 | 0.080 |
Why?
| Vagina | 1 | 2009 | 46 | 0.080 |
Why?
| Serous Membrane | 1 | 2008 | 3 | 0.080 |
Why?
| Confidentiality | 1 | 2009 | 41 | 0.080 |
Why?
| Abortion, Therapeutic | 1 | 2008 | 3 | 0.080 |
Why?
| Electrocardiography | 1 | 2010 | 268 | 0.080 |
Why?
| Efficiency, Organizational | 1 | 2009 | 41 | 0.080 |
Why?
| Recurrence | 1 | 2010 | 672 | 0.080 |
Why?
| Hot Temperature | 1 | 2009 | 214 | 0.070 |
Why?
| Sus scrofa | 2 | 2024 | 39 | 0.070 |
Why?
| Toxicity Tests | 1 | 2008 | 57 | 0.070 |
Why?
| Spinal Cord Compression | 1 | 2008 | 13 | 0.070 |
Why?
| Atrial Fibrillation | 1 | 2011 | 200 | 0.070 |
Why?
| Cardiac Catheterization | 1 | 2010 | 232 | 0.070 |
Why?
| Cervix Uteri | 1 | 2008 | 49 | 0.070 |
Why?
| Takayasu Arteritis | 1 | 2008 | 2 | 0.070 |
Why?
| Autopsy | 1 | 2008 | 48 | 0.070 |
Why?
| Gynecologic Surgical Procedures | 1 | 2008 | 28 | 0.070 |
Why?
| Evaluation Studies as Topic | 1 | 2008 | 105 | 0.070 |
Why?
| Veins | 1 | 2008 | 74 | 0.070 |
Why?
| Arteries | 1 | 2008 | 92 | 0.070 |
Why?
| Internet | 1 | 2010 | 263 | 0.070 |
Why?
| Delivery, Obstetric | 1 | 2009 | 122 | 0.070 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2008 | 37 | 0.070 |
Why?
| Costs and Cost Analysis | 1 | 2007 | 95 | 0.070 |
Why?
| Attitude to Health | 1 | 2009 | 192 | 0.070 |
Why?
| Rabbits | 1 | 2008 | 375 | 0.070 |
Why?
| Ultrasonography | 1 | 2009 | 430 | 0.070 |
Why?
| Uterus | 1 | 2007 | 88 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2010 | 294 | 0.070 |
Why?
| Sheep | 3 | 2011 | 96 | 0.070 |
Why?
| Cells, Cultured | 1 | 2008 | 1567 | 0.060 |
Why?
| Swine Diseases | 1 | 2024 | 7 | 0.060 |
Why?
| Immunocompromised Host | 1 | 2024 | 123 | 0.050 |
Why?
| Prevalence | 2 | 2020 | 1006 | 0.050 |
Why?
| Inflammation | 2 | 2017 | 641 | 0.050 |
Why?
| Leg | 1 | 2022 | 120 | 0.050 |
Why?
| Infant, Low Birth Weight | 1 | 2022 | 79 | 0.050 |
Why?
| ABO Blood-Group System | 1 | 2021 | 15 | 0.050 |
Why?
| Skin Diseases, Viral | 1 | 2011 | 2 | 0.050 |
Why?
| Simplexvirus | 1 | 2011 | 15 | 0.050 |
Why?
| International Normalized Ratio | 1 | 2011 | 28 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 121 | 0.050 |
Why?
| Heart Rate | 1 | 2022 | 318 | 0.050 |
Why?
| Bilirubin | 1 | 2011 | 43 | 0.040 |
Why?
| Colorado | 1 | 2020 | 25 | 0.040 |
Why?
| Magnetic Resonance Imaging | 1 | 2008 | 1546 | 0.040 |
Why?
| DNA, Viral | 1 | 2011 | 137 | 0.040 |
Why?
| Gestational Age | 1 | 2022 | 417 | 0.040 |
Why?
| Health Policy | 1 | 2021 | 158 | 0.040 |
Why?
| Thrombocytopenia | 1 | 2011 | 89 | 0.040 |
Why?
| Intensive Care Units, Pediatric | 1 | 2011 | 179 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 461 | 0.040 |
Why?
| Splints | 1 | 2019 | 6 | 0.040 |
Why?
| Casts, Surgical | 1 | 2019 | 9 | 0.040 |
Why?
| Intensive Care Units, Neonatal | 1 | 2011 | 135 | 0.040 |
Why?
| Anesthesia, Local | 1 | 2019 | 17 | 0.040 |
Why?
| Liver Transplantation | 1 | 2011 | 165 | 0.040 |
Why?
| Endocrine System | 1 | 2019 | 16 | 0.040 |
Why?
| Click Chemistry | 1 | 2018 | 3 | 0.040 |
Why?
| Azides | 1 | 2018 | 9 | 0.040 |
Why?
| Staining and Labeling | 1 | 2018 | 97 | 0.040 |
Why?
| Cardioplegic Solutions | 1 | 2017 | 3 | 0.040 |
Why?
| Chronic Disease | 2 | 2010 | 586 | 0.040 |
Why?
| Computer Systems | 1 | 2017 | 21 | 0.040 |
Why?
| Enterococcus | 1 | 2017 | 9 | 0.030 |
Why?
| Antiphospholipid Syndrome | 1 | 2016 | 9 | 0.030 |
Why?
| Epithelial Cells | 1 | 2018 | 215 | 0.030 |
Why?
| Pneumonectomy | 1 | 2016 | 29 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2016 | 66 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 180 | 0.030 |
Why?
| Endothelial Cells | 1 | 2018 | 262 | 0.030 |
Why?
| Specialties, Surgical | 1 | 2016 | 33 | 0.030 |
Why?
| Creatine Kinase, MB Form | 1 | 2015 | 6 | 0.030 |
Why?
| Angiography | 1 | 2016 | 114 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 151 | 0.030 |
Why?
| Wound Healing | 1 | 2016 | 219 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2016 | 944 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2015 | 591 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 1884 | 0.030 |
Why?
| Microscopy, Electron, Scanning | 1 | 2012 | 45 | 0.020 |
Why?
| Logistic Models | 1 | 2015 | 925 | 0.020 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2012 | 9 | 0.020 |
Why?
| Pancreaticoduodenectomy | 1 | 2012 | 12 | 0.020 |
Why?
| Sheep, Domestic | 1 | 2011 | 12 | 0.020 |
Why?
| Cohort Studies | 1 | 2016 | 1542 | 0.020 |
Why?
| Length of Stay | 1 | 2015 | 663 | 0.020 |
Why?
| Databases, Factual | 1 | 2015 | 706 | 0.020 |
Why?
| Rupture | 1 | 2011 | 24 | 0.020 |
Why?
| Injections, Intra-Arterial | 1 | 2010 | 13 | 0.020 |
Why?
| Salaries and Fringe Benefits | 1 | 2010 | 11 | 0.020 |
Why?
| Polystyrenes | 1 | 2010 | 5 | 0.020 |
Why?
| Microspheres | 1 | 2010 | 21 | 0.020 |
Why?
| Models, Biological | 1 | 2014 | 735 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 30 | 0.020 |
Why?
| Job Satisfaction | 1 | 2010 | 33 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2011 | 43 | 0.020 |
Why?
| Certification | 1 | 2010 | 51 | 0.020 |
Why?
| Mitral Valve Insufficiency | 1 | 2010 | 52 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 270 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 116 | 0.020 |
Why?
| Stroke Volume | 1 | 2010 | 155 | 0.020 |
Why?
| Hysterectomy | 1 | 2009 | 90 | 0.020 |
Why?
| Ventricular Function, Left | 1 | 2010 | 172 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 582 | 0.020 |
Why?
| Blotting, Western | 1 | 2010 | 590 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2011 | 181 | 0.020 |
Why?
| Phosphorylation | 1 | 2010 | 528 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 454 | 0.020 |
Why?
| Pregnancy Tests | 1 | 2008 | 2 | 0.020 |
Why?
| Uterine Hemorrhage | 1 | 2008 | 11 | 0.020 |
Why?
| Chorionic Gonadotropin | 1 | 2008 | 19 | 0.020 |
Why?
| Heart Ventricles | 1 | 2010 | 267 | 0.020 |
Why?
| Treatment Failure | 1 | 2008 | 122 | 0.020 |
Why?
| Sex Factors | 1 | 2010 | 727 | 0.020 |
Why?
| Cesarean Section | 1 | 2009 | 184 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2010 | 1229 | 0.020 |
Why?
| Pregnancy Outcome | 1 | 2008 | 250 | 0.020 |
Why?
| Pregnancy Complications | 1 | 2009 | 400 | 0.010 |
Why?
|
|
Rajab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
|